Apple Meets With Mexican Regulators Ahead of Smartwatch Debut
20 February 2015
Apple Inc. representatives met with Mexican regulators this month ahead of the debut of its smartwatches, indicating that the iPhone maker is stepping up efforts to make the new product available internationally.
Russia’s regions create modern Nuclear Medicine Centers
19 February 2015
The Orel region in Central Russia is ready to launch this coming spring its Nuclear Medicine Center for early diagnostics of cancers and cardiovascular diseases, the website of the Russian Agency for Medical and Social Information reported. The new Center is said to be supplied with “most up-to-date high-tech equipment,” including a state-of-the-art PET/CT scanner.
Atlas Genetics Aims to Bring io Platform to Market This Year after Long Delay
19 February 2015
Initially planned for a 2011 launch, Atlas Genetics' multiplex, molecular diagnostics system, called io, will hit the market four years later if the company is successful in launching it this year.
Why Eastern Europe May Be The Best Location For Your Next Clinical Trial
19 February 2015
Eastern Europe is becoming the new bright spot for clinical trials by offering significant opportunities and the fewest challenges of any of the emerging regions, according to a recent IQPC survey of pharmaceutical executives.
Cutting-edge Russian solutions for mobile medicine
19 February 2015
The Russian government has named pharma and biomed as a priority sector for innovation, and set a fairly ambitious strategic goal of increasing the share of domestic medical equipment products in the Russian market to at least 40%. It is a priority area for Marchmont to cover, too, and we have highlighted for you an ever-growing number of high tech medical projects pushed by innovators across the country.
Microsoft, Cambridge University team up on blood cancer simulation model
19 February 2015
Researchers at Microsoft ($MSFT) and the University of Cambridge have created a computer model to simulate blood cell development. The model can simulate the activity of genes tied to blood cancers, giving researchers a quick way to map the pathways that play out in leukemia and other diseases.
Russia to make its first vacuum vials
19 February 2015
Eiliton, a resident company of the Dubna special economic zone outside Moscow, is launching later this month the production of Russia’s first vacuum vials called UniVac to draw venous blood, Nanonewsnet.ru reported .
Eastern Europe Top Region for Healthcare Investments
18 February 2015
With a population of 420 million generating $4660 billion in GDP, Eastern Europe is swiftly gaining momentum as a key area for private and public investment in healthcare and health services, according to a new Frost & Sullivan Insights report.
Remote patient monitoring taking off as hospitals look to empower patients, cut costs
18 February 2015
Hospital admissions plummeted at Vidant Health-operated facilities after it started remotely monitoring patients suffering from heart failure, diabetes and high blood pressure. Patients at the University of Pittsburgh Medical Center send doctors pictures of their wounds from offsite in order to find out if they need antibiotics. And a patient at the hospital had his blood-pressure medication adjusted after he wirelessly sent the doctors biometrics from his home.
Where Does All That Biotech Venture Capital Go?
18 February 2015
Venture capital investing in biotech has long been hard to disaggregate: how much goes to “early stage” vs “late stage”, how much goes to CNS vs oncology, discovery vs Phase 3, etc…Today BIO’s David Thomas and Chad Wessel have put some much-needed light onto the biotech investor trends over the past decade with a newly released report
06 September 2024
NovaMedica expands its line of products for the treatment of Alzheimer’s disease
22 August 2024
Children visited the NovaMedica Innotech pharmaceutical manufacturing facility
14 June 2024
87% of cancer patients give positive ratings for medical care quality
18 September 2024
The Russian market of fillers and biorevitalizers grew by 21% in the first half of 2024
18 September 2024
Pharma’s Patient Reach Problem: Billions Still Left Behind
17 September 2024
17 September 2024